With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
The FDA has approved natalizumab (Tysabri) for the treatment of moderate-to-severe Crohn’s disease in patients with evidence of inflammation who have had an inadequate response to, or are…
The CDC’s FluView, a weekly influenza surveillance report prepared by the influenza division, posts the statistics for influenza week 6, February 3 – February 9, 2008. References and…
Gilbert E. D’Alonzo, MD, Professor of Medicine, Temple University School of Medicine, discusses heparin prophylaxis. References and Resources Chibbaro S, Tacconi L. Safety of deep venous thrombosis prophylaxis…
The FDA cleared for marketing the first replacement heart valve from donated human tissue in which the cells have been removed. References and Resources FDA Clears for Market…
Steven G. Kelsen, MD, FACP, FCCP, Professor of Medicine, Microbiology, and Immunology, Temple University School of Medicine, discusses how one can try to alleviate household allergens. References and…
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses pediatric emergency care. References…
Impax Laboratories Inc. received a nonapprovable letter from the FDA regarding its New Drug Application and subsequent submissions for carbidopa/levodopa extended-release tablets. The FDA’s decision was primarily based…
Steven G. Kelsen, MD, FACP, FCCP, Professor of Medicine, Microbiology, and Immunology, Temple University School of Medicine, discusses dust mites. References and Resources Thomas WR, Heinrich TK, Smith…
